Compound information
- Natural Products
- ZC3136389
- Molecular Formula
- C22H26ClN3O
- Molecular Weight
- 383.176440132 g/mol
- Structure
-
- IUPAC Name
- (5R)-1-[(4-chlorophenyl)methyl]-N-phenyl-1,9-diazaspiro[4.5]decane-9-carboxamide
- InChI
- InChI=1S/C22H26ClN3O/c23-19-10-8-18(9-11-19)16-26-15-5-13-22(26)12-4-14-25(17-22)21(27)24-20-6-2-1-3-7-20/h1-3,6-11H,4-5,12-17H2,(H,24,27)/t22-/m0/s1
- InChI Key
- AIHATYLWQGRURD-QFIPXVFZSA-N
- SMILES
- O=C(Nc1ccccc1)N1CCC[C@]2(CCCN2Cc2ccc(Cl)cc2)C1
- Source
- ZINC000096214630
Warheads
- Urea carbonyl
-
ADMET Property
Physicochemical Property
| Property | Value | Property | Value |
|---|---|---|---|
| Heavy Atom Count | 27 | Ring Count | 4 |
| Heteroatom Count | 5 | Rotatable Bond Count | 3 |
| Hydrogen Bond Acceptor Count | 2 | Hydrogen Bond Donor Count | 1 |
| Topological Polar Surface Area | 35.58 Å2 | LogP | 4.722 |
| LogS | -5.083 | LogD | 4.141 |
Absorption
| Property | Value | Property | Value |
|---|---|---|---|
| Pgp inhibitor | 0.995 | Pgp substrate | 0.079 |
| HIA | 0.972 | F20 % | 0.992 |
| F30 % | 0.958 | Caco-2 | -4.892 |
| MDCK | -5.18 |
Distribution
| Property | Value | Property | Value |
|---|---|---|---|
| BBB Penetration | 0.936 | PPB | 95.579 |
| VD | 1.593 | Fu | 1.652 |
Metabolism
| Property | Value | Property | Value |
|---|---|---|---|
| CYP1A2 inhibitor | 0.425 | CYP1A2 substrate | 0.734 |
| CYP2A6 substrate | 0.8 | CYP2B6 substrate | 0.729 |
| CYP2C19 inhibitor | 0.614 | CYP2C19 substrate | 0.873 |
| CYP2C8 substrate | 0.876 | CYP2C9 inhibitor | 0.593 |
| CYP2C9 substrate | 0.984 | CYP2D6 inhibitor | 0.973 |
| CYP2D6 substrate | 0.999 | CYP2E1 substrate | 0.97 |
| CYP3A4 inhibitor | 0.908 | CYP3A4 substrate | 0.997 |
Excretion
| Property | Value | Property | Value |
|---|---|---|---|
| T1/2 | 0.352 | CL | 8.932 |
Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| hERG Blockers | 0.993 | Hepatotoxicity | 0.701 |
| Mutagenicity | 0.0 | Rat Oral Acute Toxicity | 0.728 |
| FDAMDD | 0.607 | Skin Sensitization | 0.825 |
| Carcinogenicity | 0.079 | Eye Corrosion | 0.002 |
| Eye Irritation | 0.009 | Respiratory Toxicity | 0.96 |
Environmental Toxicity
| Property | Value | Property | Value |
|---|---|---|---|
| Bioconcentration Factors | 0.502 | IGC50 | 4.109 |
| LC50FM | 1.817 | LC50DM | -2.616 |
Tox21 Pathway
| Property | Value | Property | Value |
|---|---|---|---|
| NR-AR | 0.342 | NR-AR-LBD | 0.187 |
| NR-AhR | 0.652 | NR-Aromatase | 0.043 |
| NR-ER | 0.391 | NR-ER-LBD | 0.391 |
| NR-PPAR-gamma | 0.153 | SR-ARE | 0.86 |
| SR-ATAD5 | 0.418 | SR-HSE | 0.185 |
| SR-MMP | 0.534 | SR-p53 | 0.285 |
Similar covalent drugs
No similar covalent drugs found for this compound.